1.Potential Health Impacts of Bauxite Mining in Kuantan
Noor Hisham Abdullah ; Norlen Mohamed ; Lokman Hakim Sulaiman ; Thahirahtul Asma Zakaria ; Daud Abdul Rahim
Malaysian Journal of Medical Sciences 2016;23(3):1-8
Bauxite mining is not known to most Malaysian except recently due to environmental pollution
issues in Kuantan, Pahang. Potential impacts are expected to go beyond physical environment and
physical illness if the situation is not controlled. Loss of economic potentials, and the presence
of unpleasant red dust causing mental distress, anger and community outrage. More studies are
needed to associate it with chronic physical illness. While evidences are vital for action, merely
waiting for a disease to occur is a sign of failure in prevention. All responsible agencies should focus
on a wider aspect of health determinants rather than merely on the occurrence of diseases to act and
the need to emphasize on sustainable mining to ensure health of people is not compromised.
2.Responding to the Potential of Ebola Virus Disease (EVD) Importation into Malaysia
Wan Noraini Wan Mohamed Noor ; Sukhvinder Singh Sandhu ; Husna Maizura Ahmad Mahir ; Devan Kurup ; Norhayati Rusli ; Zainah Saat ; Chee Kheong Chong ; Lokman Hakim Sulaiman ; Noor Hisham Abdullah
Malaysian Journal of Medical Sciences 2014;21(6):3-8
The current Ebola outbreak, which is the first to affect West African countries, has been declared to have met the conditions for a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO). Thus, the Ministry of Health (MOH) of Malaysia has taken steps to strengthen and enhanced the five core components of preparedness and response to mitigate the outbreak. The National Crisis Preparedness and Response Centre (CPRC) commands, controls and coordinates the preparedness and response plans for disasters, outbreaks, crises and emergencies (DOCE) related to health in a centralised way. Through standardised case definition and mandatory notification of Ebola by public and private practitioners, surveillance of Ebola is made possible. Government hospitals and laboratories have been identified to manage and diagnose Ebola virus infections, and medical staff members have been trained to handle an Ebola outbreak, with emphasis on strict infection prevention and control practices. Monitoring of the points of entry, focusing on travellers and students visiting or coming from West African countries is made possible by interagency collaborations. To alleviate the public’s anxiety, effective risk communications are being delivered through various channels. With experience in past outbreak control, the MOH’s preparedness and response plans are in place to abate an Ebola outbreak.
3.Combination Effect of Tamoxifen and Ascorbic Acid Treatment on Breast Cancer Cells (MCF-7) and Cervical Cancer Cells (HeLa) Kesan Rawatan Kombinasi Tamoksifen dan Asid Askorbik ke atas Sel Kanser Payudara (MCF-7) dan Sel Kanser Serviks
HASMAH ABDULLAH ; NORLIDA MAMAT ; NOR MUNIRAH ZAKARIA ; NUR IMAN FATIHAH MOHD YUNAN ; MUHAMMAD IRFAN NOOR HISHAM ; HERMIZI HAPIDIN
Malaysian Journal of Health Sciences 2021;19(No.2):104-114
Breast cancer and cervical cancer are among the leading causes of death among women in the world. Even though
chemotherapy is available as cancer treatment, the development of drug resistance in both cancer cells has reduced the
efficacy of chemotherapeutic drugs in such treatment. The current study was aimed to evaluate the cell viability of
human breast cancer cells, MCF-7, and cervical cancer cells, HeLa upon the combination treatment of ascorbic acid and
tamoxifen. The cell viability was measured using the MTT assay, with an incubation period of 72 hours in a humidified
CO2
incubator. The concentrations of tamoxifen and ascorbic acid that reduced 50% of the cell population (IC50) were
determined from the dose-response curve. The IC50 concentration was used to determine the cell viability in the treated
cells. CompuSyn software was used to evaluate the combined effects towards both cells upon treatment and the results
were calculated as combination index (CI). The data were analyzed using GraphPad Prism (version 7). Statistical analysis
was performed using an independent t-test. The IC50 values of tamoxifen and ascorbic acid on MCF-7 cells were 14.53
µg/ml and 15.8 µg/ml respectively, while the IC50 values of tamoxifen and ascorbic acid on HeLa cells were 11.09 µg/ml
and 202.3 µg/ml respectively. The combination of tamoxifen and ascorbic acid exerted a greater growth reduction
percentage in both cells compared to tamoxifen alone. The results indicated that ascorbic acid synergizes the cytotoxic
effect of tamoxifen at lower concentrations towards MCF-7 cells with a CI less than 1. However, the combination of
tamoxifen and ascorbic acid exerted an antagonistic effect in HeLa cells, with a CI more than 1.